Cargando…

T-cell regulation in Erythema Nodosum Leprosum

Leprosy is a disease caused by Mycobacterium leprae where the clinical spectrum correlates with the patient immune response. Erythema Nodosum Leprosum (ENL) is an immune-mediated inflammatory complication, which causes significant morbidity in affected leprosy patients. The underlying cause of ENL i...

Descripción completa

Detalles Bibliográficos
Autores principales: Negera, Edessa, Walker, Stephen L., Bobosha, Kidist, Howe, Rawleigh, Aseffa, Abraham, Dockrell, Hazel M., Lockwood, Diana N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648259/
https://www.ncbi.nlm.nih.gov/pubmed/28991896
http://dx.doi.org/10.1371/journal.pntd.0006001
_version_ 1783272367142731776
author Negera, Edessa
Walker, Stephen L.
Bobosha, Kidist
Howe, Rawleigh
Aseffa, Abraham
Dockrell, Hazel M.
Lockwood, Diana N.
author_facet Negera, Edessa
Walker, Stephen L.
Bobosha, Kidist
Howe, Rawleigh
Aseffa, Abraham
Dockrell, Hazel M.
Lockwood, Diana N.
author_sort Negera, Edessa
collection PubMed
description Leprosy is a disease caused by Mycobacterium leprae where the clinical spectrum correlates with the patient immune response. Erythema Nodosum Leprosum (ENL) is an immune-mediated inflammatory complication, which causes significant morbidity in affected leprosy patients. The underlying cause of ENL is not conclusively known. However, immune-complexes and cell-mediated immunity have been suggested in the pathogenesis of ENL. The aim of this study was to investigate the regulatory T-cells in patients with ENL. Forty-six untreated patients with ENL and 31 non-reactional lepromatous leprosy (LL) patient controls visiting ALERT Hospital, Ethiopia were enrolled to the study. Blood samples were obtained before, during and after prednisolone treatment of ENL cases. Peripheral blood mononuclear cells (PBMCs) were isolated and used for immunophenotyping of regulatory T-cells by flow cytometry. Five markers: CD3, CD4 or CD8, CD25, CD27 and FoxP3 were used to define CD4(+) and CD8(+) regulatory T-cells. Clinical and histopathological data were obtained as supplementary information. All patients had been followed for 28 weeks. Patients with ENL reactions had a lower percentage of CD4(+) regulatory T-cells (1.7%) than LL patient controls (3.8%) at diagnosis of ENL before treatment. After treatment, the percentage of CD4(+)regulatory T-cells was not significantly different between the two groups. The percentage of CD8(+) regulatory T-cells was not significantly different in ENL and LL controls before and after treatment. Furthermore, patients with ENL had higher percentage of CD4(+) T-ells and CD4(+)/CD8(+) T-cells ratio than LL patient controls before treatment. The expression of CD25 on CD4(+) and CD8(+) T-cells was not significantly different in ENL and LL controls suggesting that CD25 expression is not associated with ENL reactions while FoxP3 expression on CD4(+) T-cells was significantly lower in patients with ENL than in LL controls. We also found that prednisolone treatment of patients with ENL reactions suppresses CD4(+) T-cell but not CD8(+) T-cell frequencies. Hence, ENL is associated with lower levels of T regulatory cells and higher CD4(+)/CD8(+) T-cell ratio. We suggest that this loss of regulation is one of the causes of ENL.
format Online
Article
Text
id pubmed-5648259
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-56482592017-11-03 T-cell regulation in Erythema Nodosum Leprosum Negera, Edessa Walker, Stephen L. Bobosha, Kidist Howe, Rawleigh Aseffa, Abraham Dockrell, Hazel M. Lockwood, Diana N. PLoS Negl Trop Dis Research Article Leprosy is a disease caused by Mycobacterium leprae where the clinical spectrum correlates with the patient immune response. Erythema Nodosum Leprosum (ENL) is an immune-mediated inflammatory complication, which causes significant morbidity in affected leprosy patients. The underlying cause of ENL is not conclusively known. However, immune-complexes and cell-mediated immunity have been suggested in the pathogenesis of ENL. The aim of this study was to investigate the regulatory T-cells in patients with ENL. Forty-six untreated patients with ENL and 31 non-reactional lepromatous leprosy (LL) patient controls visiting ALERT Hospital, Ethiopia were enrolled to the study. Blood samples were obtained before, during and after prednisolone treatment of ENL cases. Peripheral blood mononuclear cells (PBMCs) were isolated and used for immunophenotyping of regulatory T-cells by flow cytometry. Five markers: CD3, CD4 or CD8, CD25, CD27 and FoxP3 were used to define CD4(+) and CD8(+) regulatory T-cells. Clinical and histopathological data were obtained as supplementary information. All patients had been followed for 28 weeks. Patients with ENL reactions had a lower percentage of CD4(+) regulatory T-cells (1.7%) than LL patient controls (3.8%) at diagnosis of ENL before treatment. After treatment, the percentage of CD4(+)regulatory T-cells was not significantly different between the two groups. The percentage of CD8(+) regulatory T-cells was not significantly different in ENL and LL controls before and after treatment. Furthermore, patients with ENL had higher percentage of CD4(+) T-ells and CD4(+)/CD8(+) T-cells ratio than LL patient controls before treatment. The expression of CD25 on CD4(+) and CD8(+) T-cells was not significantly different in ENL and LL controls suggesting that CD25 expression is not associated with ENL reactions while FoxP3 expression on CD4(+) T-cells was significantly lower in patients with ENL than in LL controls. We also found that prednisolone treatment of patients with ENL reactions suppresses CD4(+) T-cell but not CD8(+) T-cell frequencies. Hence, ENL is associated with lower levels of T regulatory cells and higher CD4(+)/CD8(+) T-cell ratio. We suggest that this loss of regulation is one of the causes of ENL. Public Library of Science 2017-10-09 /pmc/articles/PMC5648259/ /pubmed/28991896 http://dx.doi.org/10.1371/journal.pntd.0006001 Text en © 2017 Negera et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Negera, Edessa
Walker, Stephen L.
Bobosha, Kidist
Howe, Rawleigh
Aseffa, Abraham
Dockrell, Hazel M.
Lockwood, Diana N.
T-cell regulation in Erythema Nodosum Leprosum
title T-cell regulation in Erythema Nodosum Leprosum
title_full T-cell regulation in Erythema Nodosum Leprosum
title_fullStr T-cell regulation in Erythema Nodosum Leprosum
title_full_unstemmed T-cell regulation in Erythema Nodosum Leprosum
title_short T-cell regulation in Erythema Nodosum Leprosum
title_sort t-cell regulation in erythema nodosum leprosum
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648259/
https://www.ncbi.nlm.nih.gov/pubmed/28991896
http://dx.doi.org/10.1371/journal.pntd.0006001
work_keys_str_mv AT negeraedessa tcellregulationinerythemanodosumleprosum
AT walkerstephenl tcellregulationinerythemanodosumleprosum
AT boboshakidist tcellregulationinerythemanodosumleprosum
AT howerawleigh tcellregulationinerythemanodosumleprosum
AT aseffaabraham tcellregulationinerythemanodosumleprosum
AT dockrellhazelm tcellregulationinerythemanodosumleprosum
AT lockwooddianan tcellregulationinerythemanodosumleprosum